Semnur Pharmaceuticals, Inc. (SMNR)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
| Metric (FY) | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | — | $50.00M | — | — |
| Operating Income | -$160.42M | -$4.69M | -$3.17M | — |
| Net Income | -$160.42M | -$4.69M | $632.5K | -$419.4K |
| EPS (Diluted) | $-0.78 | $-0.02 | — | — |
| Total Assets | $1.35M | $6.68M | $50.69M | $86.28M |
| Total Liabilities | $22.10M | $49.47M | $8.49M | $4.18M |
| Shareholders' Equity | -$20.75M | -$42.78M | -$38.09M | -$3.27M |
| Cash & Equivalents | $20.0K | $12.0K | $204.5K | $819.7K |
| Operating Cash Flow | -$5.87M | -$4.89M | -$632.8K | -$426.1K |
| Shares Outstanding | 230.21M | 200.00M | — | — |